Evlo stocks.

Track Evelo Biosciences Inc (EVLO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable …EVLO is trading at a 54% discount. Price $0.48 Nov 24, 2023 Fair Value $4.36 Nov 24, 2023 Uncertainty Extreme 1-Star Price $93.93 5-Star Price $7.34Stock analysis for Evolution AB (EVO:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.EVLO) stock’s latest price update. The stock of Evelo Biosciences Inc (NASDAQ: EVLO) has decreased by -32.65 when compared to last closing price of 0.73.Despite this, the company has seen a gain of 62.37% in its stock price over the last five trading days. Benzinga reported 2023-10-20 that The most oversold stocks in the health care sector ...Nov 20, 2023 · According to analyst projections, EVLO’s forecast low is $10.00 with $10.00 as the target high. To hit the forecast high, the stock’s price needs a -1718.18% plunge from its current level, while the stock would need to soar -1718.18% for it to hit the projected low. Evelo Biosciences Inc (EVLO) estimates and forecasts

You can buy or sell EVLO and other ETFs, options, and stocks. View the real-time EVLO price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd ...According to . 1 Wall Street analyst that have issued a 1 year EVLO price target, the average EVLO price target is $10.00, with the highest EVLO stock price forecast at $10.00 and the lowest EVLO stock price forecast at $10.00.EVLO's short-term technical score of 10 indicates that the stock has traded less bullishly over the last month than 90% of stocks on the market. In the Biotechnology industry, which ranks 116 out of 146 industries, the stock ranks higher than 14% of stocks. Evelo Biosciences Inc has risen 23.85% over the past month, closing at $2.11 on June 7.

See EVLO Report. Evelo Biosciences Inc ( EVLO) is around the top of the Healthcare sector according to InvestorsObserver . EVLO received an overall rating of 14, which means that it scores higher than 14% of stocks. Additionally, Evelo Biosciences Inc scored a 71 in the Healthcare sector, ranking it higher than 71% of stocks in that sector.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

Evelo Biosciences, Inc. Common Stock (EVLO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Which Evelo Biosciences insiders have been selling company stock? The following insiders have sold EVLO shares in the last 24 months: Duncan Mchale ($8,673.60), Marella Thorell ($24,663.27), Mark Bodmer ($33,949.47), Simba Gill ($11,631.02), and Stephen J Carriere ($148.40).EVLO | Complete Evelo Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. EVLO stock is up 51.3% as of Tuesday morning. Investors seeking out more of the most recent stock market news will want to stick around! We have all of the hottest stock market news that traders ...

During the last day, the stock moved $0.0291 between high and low, or 7.27%. For the last week the stock has had daily average volatility of 19.21%. Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set. Trading Expectations (EVLO) For The Upcoming Trading Day Of Thursday 30th

View the latest Evelo Biosciences Inc. (EVLO) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Oct 17, 2023 · CAMBRIDGE, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO) (“Evelo” or the “Company”), a clinical stage biotechnology company developing a novel platform of ... EVLO shares gained +28.6% the day following the earnings announcement to close at 12.94. Following its earnings release, 99 days ago, EVLO stock has drifted - ...Evelo Biosciences Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-1.400 per share for the current fiscal year. Evelo Biosciences Inc does not currently pay a dividend.Evelo Biosciences (EVLO) is down ~39% Friday after a ~13.2M common stock offering began today.Early Friday morning, the SEC provided a notice of effectiveness allowing the proposed...This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors. What's Happening With Evelo Biosciences Inc Stock Today? Evelo Biosciences Inc (EVLO) stock is trading at $0.55 as of 12:29 PM on Monday, Nov 20, an increase of $0.06, or 11.98% from the previous closing price of $0.49.Assess today's live Evelo Biosciences Inc (EVLO) share price, performance and insights using our live NASDAQ: EVLO stock exchange data. Analyse historical data and Evelo Biosciences Inc share price performance charts on this page. Our technical summary section provides analysis on Evelo Biosciences share price buy/sell indicators using real …Find the latest Evolution AB (publ) (EVO.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 22, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Evelo Biosciences stock is Reduce based on the current 1 sell rating and 3 hold ratings for EVLO. The average twelve-month price prediction for Evelo Biosciences is $70.00 with a high price target of $100.00 and a low price target of $40.00. The intrinsic value of EVLO. FMR LLC ( Trades, Portfolio) acquired 2,325,827 shares of Evelo Biosciences Inc ( NASDAQ:EVLO) on July 31, 2023, at a price of $10.47 per share. This transaction ...Jul 18, 2023 · This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking. What's Happening With Evelo Biosciences Inc Stock Today? Evelo Biosciences Inc (EVLO) stock is trading at $4.12 as of 11:07 AM on Tuesday, Jul 18, an increase of $0.57, or 16.06% from the previous closing price of $3.55. What Makes Evelo Biosciences, Inc. (EVLO) a New Buy Stock 05/17/23-11:00AM EST Zacks Forget Bargain Hunting, Buy 4 Stocks With Rising P/E 03/16/23-5:53AM EST ZacksView the latest Evelo Biosciences Inc. (EVLO) stock price, news, historical charts, analyst ratings and financial information from WSJ.Get the latest news and real-time alerts from Evelo Biosciences, Inc. (EVLO) stock at Seeking Alpha.

Flagship Pioneering, an investment vehicle helmed by Noubar Afeyan, a co-founder of Moderna and its chairman, bought $12.5 million of shares of biotech Evelo.Jul 5, 2023 · EVLO's short-term technical score of 10 indicates that the stock has traded less bullishly over the last month than 90% of stocks on the market. In the Biotechnology industry, which ranks 116 out of 146 industries, the stock ranks higher than 14% of stocks. Evelo Biosciences Inc has risen 23.85% over the past month, closing at $2.11 on June 7.

Moreover, EVLO currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises.Analyzing EVLO Stock Performance. On Thursday, Evelo Biosciences Inc [NASDAQ: EVLO] plunged -19.35% to $0.31. The stock’s lowest price that day was $0.3007, but it reached a high of $0.3799 in the same session. During the last five days, there has been a drop of approximately -49.23%.Evelo's (EVLO) EDP2939 fails to achieve the primary endpoint in a mid-stage for treating moderate psoriasis. The company decides to cease clinical development on the candidate. Find the latest Evelo Biosciences, Inc. (EVLO) stock quote, history, news and other vital information to help you with your stock trading and investing.Chg %. $0.8000. -0.0883. -9.94%. Evelo Biosciences Inc. advanced stock charts by MarketWatch. View EVLO historial stock data and compare to other stocks and exchanges.Nov 21, 2023 ... Evelo Biosciences Inc (EVLO) stock has risen 82.35% over the past week and gets a Neutral rating from InvestorsObserver Sentiment Indicator.Product. Stock ScreenerStock IdeasMetrics ExplorerChart EditorWatchlists. Social. BlogTwitterFacebookInstagramLinkedIn All rights reserved. Terms Of Use.EVLO stock is up 51.3% as of Tuesday morning. Investors seeking out more of the most recent stock market news will want to stick around! We have all of the hottest stock market news that traders ...The consensus among analysts is that Evelo Biosciences Inc (EVLO) is an Underweight stock at the moment, with a recommendation rating of 4.00. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 2 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per …Mar 1, 2023 · Moreover, EVLO currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. May 17, 2023 · Evelo Biosciences, Inc. (EVLO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

IPO Date May 9, 2018 Employees 66 Stock Exchange NASDAQ Ticker Symbol EVLO Full Company Profile Financial Performance Financial Statements Analyst …

Evelo Biosciences, Inc. (EVLO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Earnings Date. Jan 31, 2024 - Feb 05, 2024. Forward Dividend & Yield. 22.72 (2.09%) Ex-Dividend Date. Apr 05, 2023. 1y Target Est. 1,379.66. Fair Value is the appropriate price for the shares of a ...Jul 18, 2023 ... Evelo Biosciences Inc (EVLO) stock is trading at $4.12 as of 11:07 AM on Tuesday, Jul 18, an increase of $0.57, or 16.06% from the previous ...50.80%. Get the latest Evelo Biosciences Inc (EVLO) real-time quote, historical performance, charts, and other financial information to help you make more informed …Evelo Biosciences Inc EVLO released top-line results from its Phase 2 clinical study with EDP2939 in moderate psoriasis. EDP2939 is a next-generation product candidate based on previously reported ...EVLO) stock’s latest price update. The stock of Evelo Biosciences Inc (NASDAQ: EVLO) has decreased by -32.65 when compared to last closing price of 0.73.Despite this, the company has seen a gain of 62.37% in its stock price over the last five trading days. Benzinga reported 2023-10-20 that The most oversold stocks in the health care sector ...EVLO stock had an eventful day on October 17, 2023, with analysts offering a wide range of price forecasts. The median estimate of $6.50 represented a substantial increase from the last recorded price, indicating optimism in the market. However, the consensus among polled investment analysts was to hold the stock, suggesting a …EVLO stock is up 78.2% as of Thursday morning. Investors will want to stick around for more of the most recent stock market news! We’ve got all of the latest details moving stocks on Thursday!

Evelo Biosciences Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-1.400 per share for the current fiscal year. Evelo Biosciences Inc does not currently pay a dividend.During the last day, the stock moved $0.0291 between high and low, or 7.27%. For the last week the stock has had daily average volatility of 19.21%. Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set. Trading Expectations (EVLO) For The Upcoming Trading Day Of Thursday 30thNov 27, 2023 · For their last quarter, Evelo Biosciences (EVLO) reported earnings of -$0.66 per share, beating the Zacks Consensus Estimate of $-1.34 per share. This reflects a positive earnings surprise of 50. ... Evelo Biosciences (EVLO) Stock Price Performance. Evelo Biosciences (EVLO) Stock Key Data. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months.Instagram:https://instagram. best vanguard mutual funds 2023small tech companies to invest inschwab us broad market etfindependent contractor tax percentage EVLO stock is up 78.2% as of Thursday morning. Investors will want to stick around for more of the most recent stock market news! We’ve got all of the latest details moving stocks on Thursday!Here Are Other Stocks Moving In Thursday's Mid-Day Session msn.com - June 29 at 3:44 PM: Evelo Biosciences Announces Reverse Stock Split Effective finance.yahoo.com - June 29 at 9:42 AM: EVLO - Evelo Biosciences, Inc. finance.yahoo.com - June 22 at 12:44 AM: Why Is Evelo Biosciences (EVLO) Stock Up 51% Today? investorplace.com - June 20 at 10:06 AM bpop stockvr madden Stock analysis for Evelo Biosciences Inc (EVLO:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Heron therapeutics stock moved upwards by 63.0% to $0.88 during wednesday's regular session. Kinnate biopharma shares increased by 57.32% after the company's, q3 earnings came out yesterday. Gossamer bio (nasdaq:goss) shares rose 30.09% and mira pharmaceuticals stock increased by 34.5% during the session. Webull offers EVLO Ent … insider stock trading tracker EVLO After-Hours Quotes. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of ...What this means: InvestorsObserver gives Evelo Biosciences Inc (EVLO) an overall rank of 35, which is below average. Evelo Biosciences Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system.